Meiditai Launches JCRing X3 Non-Invasive Blood Glucose Smart Ring with Medical-Grade BGEM Algorithm

Preventive Health Moves to the Finger

Dongguan Meiditai Technology & Trade Co., Ltd. has released the JCRing X3, a medical-grade, non-invasive blood glucose risk assessment smart ring built for distributors, pharmacy chains, insurance wellness programs and corporate health projects. Instead of asking users to prick a finger, the JCRing X3 applies an innovative BGEM (blood glucose evaluation and monitoring) algorithm to continuous physiological signals and produces a daily diabetes risk assessment that consumers can read inside the JCRing app.

The launch responds to a clear shift in the wearable market: buyers no longer treat rings as fashion accessories. They expect a device that collects meaningful health data every day, presents it clearly and integrates with the platforms their customers already use.

What the JCRing X3 Delivers

• Non-invasive glucose risk assessment: the BGEM algorithm evaluates diabetes risk from ring-based signals, with no strips, lancets or disposable sensors.
• 24-hour vital monitoring: automatic and manual measurement of heart rate, blood oxygen (SpO2) and blood pressure trends, with configurable measurement intervals through the app.
• Sleep and recovery insight: light, deep and REM sleep stages, wake time, time in bed, plus sleep efficiency scoring.
• Activity and sport tracking: steps, calories, distance, active duration, daily goal achievement and multi-sport modes with automatic walking, running and cycling recognition.
• Advanced wellness algorithms: VO2max cardio-pulmonary assessment and OSA (obstructive sleep apnea) risk monitoring, both delivered as cloud-based algorithm services.
• Family health groups: members can share data, set abnormal-value alerts and follow each other's status in real time without distance limits.
• 5ATM water resistance: suitable for swimming, washing hands and all-day wear.

Key Specifications

Why Distributors Are Moving Early

Three factors make the JCRing X3 easy to position. First, the product tells a simple story: a ring on the finger, a glucose risk score on the phone, no consumables to reorder. Second, it covers the vital signs retailers already merchandise, including heart rate, SpO2, blood pressure, sleep and VO2max, so one SKU fills several shelf categories. Third, the titanium alloy case and resin body give the ring a premium feel that supports higher retail price points than entry-level fitness bands.

For pharmacy and insurance channels, the family health group function is particularly relevant. Members can monitor elderly parents or chronic-condition patients remotely, and abnormal readings trigger alerts, which creates a natural subscription and service conversation.

OEM, ODM and SDK Opportunities

Meiditai offers the JCRing X3 as a private-mold platform. Buyers can customize the logo, packaging and app skin, request firmware adjustments, and integrate the device into their own applications through the SDK and API. OEM and ODM projects are supported for partners who want a differentiated product rather than a catalog item.

The advanced BGEM, VO2max and OSA algorithms are cloud-based services. Partners who want to run these functions inside their own servers or applications can discuss integration and development terms directly with the Meiditai team.

All devices are produced in Guangdong, China, under CE, RoHS and FCC compliance, with quality control applied across the supply chain.

Availability

The JCRing X3 is available now for sample orders and volume programs. Minimum order quantity starts at one unit for evaluation, reference price is US$265 per unit, and standard delivery is 4 to 5 days under T/T payment terms. Distributors, pharmacy groups and wellness platform operators can contact Dongguan Meiditai Technology & Trade Co., Ltd. for quotations, SDK documentation and private-label discussions.